Kisspeptin-10

Kisspeptin-10 (KISS1R agonist) is a decapeptide (10 amino acids). The HEIVE catalog describes it as: The upstream switch of the reproductive axis. It signals the hypothalamus to release GnRH — one step earlier than anything else here acts. It is also known as KP-10 and Metastin.

HEIVE groups Kisspeptin-10 under libido, erectile function, fertility, hormonal balance and emotional balance. These catalog categories are not approved indications or evidence that treatment works. See the product-specific regulatory answer below.

No matching FDA product was identified for Kisspeptin-10 under the searched names in the October 6, 2026 Drugs@FDA snapshot. This name search does not establish worldwide approval status or exclude differently named products. FDA describes safety concerns or insufficient safety information for the corresponding substance on its compounding-risk page; that listing is not a drug approval.

• FDA product data (October 6, 2026)
• FDA compounding safety information

The HEIVE editorial risk summary for Kisspeptin-10 lists: Flushing and a brief blood-pressure dip. The half-life is minutes, so effects arrive and leave inside the hour. Longer-term concerns: Unknown past trial durations. Daily dosing risks receptor desensitisation — the opposite of the intent. This is not a complete or clinically reviewed safety assessment; risks depend on the product, route and population.

Kisspeptin-10 has no single onset time established by this catalog. The editorial timeline starts with “First doses · hours”. These are illustrative model or editorial milestones, not clinically validated outcome predictions.

HEIVE's illustrative catalog entry for Kisspeptin-10: 100 mcg subcutaneously, two to three times a week. This is not a verified study range or a prescription. A dose cannot be transferred between products, routes or indications; use the specific approved label and the prescribing clinician's instructions where applicable.

The catalog classifies Kisspeptin-10 as having human research. Its paper-count snapshot is not a live PubMed search, a count of controlled human trials or proof of safety. This FAQ has not independently validated the catalog's clinical literature claims.

The source catalog lists a nasal form for Kisspeptin-10. A listed form is not evidence of an approved or effective treatment. Nasal forms are listed in the source catalog; this does not establish approval, efficacy or equivalent absorption. HEIVE injection calculations do not apply to nasal forms.

Preparation of Kisspeptin-10 depends on the exact labeled product. Follow its instructions for formulation, diluent, route and storage. A generic powder recipe must not be applied to a prefilled, ready-to-use or differently formulated product. The catalog's mixing example does not establish sterility or stability.

Storage for Kisspeptin-10 depends on the specific formulation (injectable and nasal in the source catalog). Follow the product's labeled temperature, light protection and expiry or discard instructions. A general refrigerator or 28-day rule does not establish stability or sterility for every preparation.

The HEIVE editorial summary for Kisspeptin-10: Real. Space the doses; do not run it daily. This summary is not a clinically validated prediction of tolerance or withdrawal for an individual.

Kisspeptin-10 and hCG share the catalog categories hormonal balance, fertility and libido. Kisspeptin-10: The upstream switch of the reproductive axis. It signals the hypothalamus to release GnRH — one step earlier than anything else here acts. hCG: A pregnancy hormone that reads as LH at the testicular receptor. Licensed for fertility and hypogonadism, and the standard way to keep your own production running on testosterone therapy. This is a catalog comparison, not a head-to-head clinical result or a recommendation to substitute treatments.

• View hCG

The HEIVE editorial summary highlights: Brain-imaging trials in men with low desire found arousal circuitry changed before any hormone did. The cited study, population and formulation must be checked before treating this summary as a clinical finding; this FAQ does not supply a verified research citation for it.